Page last updated: 2024-08-24

2,6-dimethyl-1,4-benzoquinone and Lung Neoplasms

2,6-dimethyl-1,4-benzoquinone has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dong, Z; Kim, DJ; Laster, K; Xie, X; Zu, X1

Other Studies

1 other study(ies) available for 2,6-dimethyl-1,4-benzoquinone and Lung Neoplasms

ArticleYear
2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells.
    Journal of pharmacological sciences, 2021, Volume: 145, Issue:3

    Topics: Antineoplastic Agents; Benzoquinones; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; MAP Kinase Signaling System; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2021